Sign in
Taking people in United StatesNo phase

Vibrant capsule for bowel problems after spinal cord injury

Tests the Vibrant capsule for neurogenic bowel in people with spinal cord injury.

Key facts

Who runs it
The University of Texas Health Science Center, Houston
Where
Houston, United StatesSee the site
Trial code
Registry title
Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction
Status
Recruiting
People taking part
12 people, planned
Started
6 Jan 2026
Planned end
19 Aug 2026
Type of study
Interventional
Treatments tested
  • Vibrant Capsule
Record updated
21 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a long-term spinal cord injury and bowel problems caused by the nerve damage. It tests the Vibrant capsule device.

Age
21 Years and older
Sex
All sexes
Disease stage
Chronic spinal cord injury for more than one year. The nerve level and function have been stable for at least six months.
Earlier treatment
A steady bowel routine with no changes for at least 3 months. At least one planned bowel movement every three days. The routine uses finger stimulation, suppositories, enemas or mini enemas, plus medicines taken by mouth.

Main reasons for not taking part

  • Bowel leakage more than once per week
  • Past bowel blockage, ileus, diverticulitis or bowel surgery for a disease (appendix removal is allowed)
  • Ongoing dangerous blood pressure spikes (autonomic dysreflexia) set off by bowel movements
  • Swallowing problems or food pipe diseases, such as narrowing, Zenker's diverticulum, eosinophilic esophagitis or achalasia
  • Pregnancy, implanted devices that a magnetic field could affect, or not speaking English

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Individuals with chronic spinal cord injury (SCI) of more than one year
  • Stable neurological level and function of SCI for at least six months
  • Consistent bowel program without changes for at least 3 months
  • At least one scheduled bowel movement (BM) every three days
  • Use of digital stimulation, suppositories, enemas, or mini enemas, as part of the scheduled bowel program
  • Use of oral medications as part of the bowel program

Who cannot take part

  • Recent changes to spasticity medications within the past month
  • History of bowel obstruction, ileus, diverticulitis, or bowel surgery for a disease (appendix removal is ok)
  • History of significant gastrointestinal disorders
  • History of Zenker's diverticulum
  • Bowel incontinence occurring more than once per week
  • Non-English-speaking individuals
  • Persistent autonomic dysreflexia (AD) triggered by bowel movements
  • Dysphagia
  • Esophageal stricture
  • Eosinophilic esophagitis or achalasia
  • Pregnancy
  • Presence of implanted devices that could be affected by proximity to a direct current magnetic field

This trial is currently available in United States.

  • TIRR Memorial HermannHouston, United StatesContact: Danira Garcia Gutierrez, BSTaking people

About the trial

What the trial wants to find out

The goal of this study is to test the safety and effectiveness of Vibrant capsules in spinal cord injury patients with neurogenic bowel.

The group in the trial

  • Vibrant CapsuleTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pilot Trial of the Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction
Plain-language title
Vibrant capsule for bowel problems after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 August 2026